California Ban on Flavored Tobacco Upheld by Supreme Court

Dec.21.2022
California Ban on Flavored Tobacco Upheld by Supreme Court
A California ban on flavored tobacco products is upheld by the US Supreme Court, despite RJ Reynolds' appeal.

On November 8, 2022, voters in California approved Proposition 31, a referendum on the 2020 law that would ban the retail sale of certain flavored tobacco products.


Less than three weeks later, lawyers representing RJ Reynolds Tobacco Company, RJ Reynolds Vapor Company, and other Reynolds tobacco subsidiaries filed an emergency lawsuit with the US Supreme Court seeking to prohibit the proposal and enforcement of Senate Bill 793.


Across the state, more than 63% of voters support the proposal, with even 55% of voters in Riverside County voting in favor. However, Reynolds was not deterred and has appealed to the Supreme Court on November 29th.


This week, the Supreme Court of the United States rejected the appeal.


Reynolds' lawyers argued that the Tobacco Control Act (Public Law 111-31, approved in June 2009) prohibits states and local jurisdictions from enacting tobacco product standards that differ from federal standards. Furthermore, the federal government has not yet banned these flavored tobacco products.


Both the district court and the Ninth Circuit Court of Appeals did not prevent the enforcement of SB 793, which is why Reynolds appealed to the Supreme Court. The Ninth Circuit Court of Appeals had previously been overturned in cases related to the law.


According to documents submitted by Reynolds' lawyers, "this request stems from the Ninth Circuit Court's decision to effectively ignore the explicit priority purchase provisions of the Tobacco Control Act and allow states to completely prohibit the sale of flavored tobacco products that do not meet the state's tobacco product standards. If judicial intervention is not immediately taken, the petitioners will suffer irreparable harm, as they will be unable to sell their products in one of the largest markets in the United States.


In response, the California Department of Justice told the court that Reynolds is more concerned with those unable to purchase flavored products, as opposed to the millions of children and teenagers who have become smokers after using these products. The state highlighted that Reynolds' research, which contradicts this point, was prepared by one of its affiliated organizations and not independently.


The state argues that the implementation of SB 793 has been delayed for almost two years by unsuccessful public campaigns, allowing children and teenagers throughout the state to develop the deadly habit of tobacco use through flavored tobacco products during this period. Voters have now spoken by rejecting the tobacco industry's policy arguments and approving the ban on the retail sale of flavored tobacco products. The balance has been decisively tipped, enabling the will of the voters to take effect.


The Supreme Court declined to comment or raise any objections, instead issuing a brief statement rejecting Reynolds' appeal, stating: "The injunction application submitted to Judge Cogan and submitted to the Court by her is denied.


After the Supreme Court ruling, California Attorney General Rob Bonta praised the decision in a press release, stating "At a time when tobacco is America's number one preventable killer, flavored tobacco products are attracting a new generation of young smokers. I commend the Supreme Court for rejecting Big Tobacco's recent attempt to block California's common-sense ban on flavored tobacco products. California voters overwhelmingly passed this ban in November's election and now it will finally go into effect. I look forward to continuing to defend this important law against any further legal challenges.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | SnowPlus Launches Nicotine-Free DASH in South Korea, Localising an Established Disposable Platform
Product | SnowPlus Launches Nicotine-Free DASH in South Korea, Localising an Established Disposable Platform
SnowPlus has introduced a nicotine-free version of DASH in South Korea, adapting an existing overseas disposable platform for the local market. The Korean version retains the series’ flat duckbill-style mouthpiece, ceramic heating architecture and disposable form factor while reducing nicotine content to 0%. By comparison, the overseas DASH 4000 platform typically features 7.5ml of prefilled e-liquid, up to 4,000 puffs and a 530mAh rechargeable battery, with nicotine-containing variants available in some markets. The product update centers on formulation localisation rather than a new hardware generation.
Aug.31
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands has agreed to acquire 100% of Swedish modern oral nicotine company Yoik Group AB for an initial SEK515 million, equivalent to about US$53.9 million, plus a deferred payment linked to performance over the next two years. Yoik owns nicotine pouch brand Helwit, which held about 3.4% of Sweden’s modern oral nicotine market over the past 12 months. Imperial says the acquisition will more than double its existing share of the Swedish market. Helwit is also sold elsewhere in the Nordics, through European online channels and in selected UK retail outlets.
Sep.08
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's parliament is scheduled to hold a first reading of amendments to the Tobacco Tax Act on September 24. The government plans annual tax increases from 2027 through 2030 covering cigarettes, heated tobacco, vaping liquids and other categories. It expects the reform to generate €756 million in additional revenue in 2027, rising to €3.589 billion in additional annual revenue by 2030. Ahead of the parliamentary debate, the German Association of the Tobacco Industry and Novel Products, or BVTE, launched the "Tabaksteuer mit Augenmaß" campaign backed by BAT, JTI, Philip Morris, Reemtsma and wholesale and retail groups.
Sep.23
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Swedish nicotine pouch brand Kelly White is building its strategy around adult female consumers. Founder and CEO Sophia Wilsby told 2Firsts that women accounted for around 70% of the brand’s repeat customers on HAYPP in Sweden in 2025. The interview explores female consumer segmentation, product and design differentiation, gender stereotypes, packaging regulation, and how independent brands can compete with global players such as ZYN and VELO while considering funding, partnerships and future ownership options.
Business
Sep.24
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03